The most prominent prognostic blood biomarker for both arrhythmia-free survival and intervention-free survival was NT-proBNP, whereas the most important prognostic echocardiographic biomarkers were LV mass index and indicators for diastolic LV dysfunction, especially LA enlargement. Here, NPPB is linked to cardiac arrhythmia.